Undiscovered Amazon drugs could be valued at $215 billion, analysis finds
An analysis cited by Mongabay estimates that undiscovered medicines from Amazon species could have a potential value of $215 billion. The report warns that tree loss may eliminate species with medical potential before scientists identify or study the compounds they contain, linking deforestation to possible losses in future drug discovery.

An analysis cited by Mongabay estimates that undiscovered medicines from species in the Amazon could be worth $215 billion.
The report warns that as trees are lost, species that might yield lifesaving medicines could disappear before scientists identify their medical potential.
THE QUESTIONS THIS EVENT LEAVES BEHIND
What assumptions underpin the $215 billion valuation?
Which Amazon species face the greatest risk of disappearing before they are studied?
Who would control or benefit from medicines developed from Amazon biodiversity?
How much of the potential value depends on compounds that have not yet been identified?
What conservation measures could reduce the risk of losing species with medical potential?
YOUR QUESTION
Does this story leave you with another question?
Send us the question the report did not answer. It may become the next question IAQ investigates.
GLOBAL CURIOSITY MAP · SEPTEMBER 2026